Abstract:Abstract Background Cerebral arteriovenous malformation (AVM) is a serious life-threatening congenital cerebrovascular disease. Specific anatomical features, such as nidus size, location, and venous drainage, have been validated to affect treatment outcomes. Until recently, molecular biomarkers and corresponding molecular mechanism related to anatomical features and treatment outcomes remain unknown. Methods RNA N6-methyladenosine (m 6 A) Methyltransferase METTL3 was identified as a differentially expressed gene in groups with different lesion sizes by analyzing the transcriptome sequencing (RNA-seq) data. Tube formation and wound healing assays were performed to investigate the effect of METTL3 on angiogenesis. In addition, Methylated RNA Immunoprecipitation Sequencing technology (MeRIP-seq) was performed to screen downstream targets of METTL3 in endothelial cells and to fully clarify the specific underlying molecular mechanisms affecting the phenotype of cerebral AVM. Results In the current study, we found that the expression level of METTL3 was reduced in the larger pathological tissues of cerebral AVMs. Moreover, knockdown of METTL3 significantly affected angiogenesis of the human endothelial cells. Mechanistically, down-regulation of METTL3 reduced the level of heterodimeric Notch E3 ubiquitin ligase formed by DTX1 and DTX3L, thereby continuously activating the Notch signaling pathway. Ultimately, the up-regulated downstream genes of Notch signaling pathway dramatically affected the angiogenesis of endothelial cells. In addition, we demonstrated that blocking Notch pathway with DAPT could restore the phenotype of METTL3 deficient endothelial cells. Conclusions Our findings revealed the mechanism by which m 6 A modification regulated the angiogenesis and might provide potential biomarkers to predict the outcome of treatment, as well as provide suitable pharmacological targets for preventing the formation and progression of cerebral AVM.

METTL3-dependent m 6 A modification of PSEN1 mRNA regulates craniofacial development through the Wnt/β-catenin signaling pathway

METTL5 Regulates Cranial Suture Fusion Via Wnt Signaling

METTL3 Modulates Ctsk+ Lineage Supporting Cranial Osteogenesis via Hedgehog

Methyltransferase METTL3 governs the modulation of SH3BGR expression through m6A methylation modification, imparting influence on apoptosis in the context of Down syndrome-associated cardiac development

Mettl5 mediated 18S rRNA N6-methyladenosine (m6A) modification controls stem cell fate determination and neural function

METTL3-Dependent N6-Methyladenosine Modification Programs Human Neural Progenitor Cell Proliferation

METTL3-mediated pre-miR-665/DLX3 m 6 A methylation facilitates the committed differentiation of stem cells from apical papilla

Mettl3 Mutation Disrupts Gamete Maturation and Reduces Fertility in Zebrafish

N6-methyladenosine methyltransferase METTL3 affects the phenotype of cerebral arteriovenous malformation via modulating Notch signaling pathway

Single-cell Transcriptomic Signatures and Gene Regulatory Networks Modulated by Wls in Mammalian Midline Facial Formation and Clefts.

amer1 Regulates Zebrafish Craniofacial Development by Interacting with the Wnt/β-Catenin Pathway

METTL3 ‐Mediated m 6 A mRNA Methylation Modulates Tooth Root Formation by Affecting NFIC Translation

[METTL3 Regulates Expression of Pluripotent Genes in Porcine Pluripotent Stem Cells].

METTL3-Mediated M6a Mrna Methylation Modulates Tooth Root Formation by Affecting NFIC Translation

Role Of Epigenetic M(6)A Rna Methylation In Vascular Development: Mettl3 Regulates Vascular Development Through Phlpp2/Mtor-Akt Signaling

METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma

METTL3 Promotes Proliferation and Myogenic Differentiation Through M6a RNA Methylation/ythdf1/2 Signaling Axis in Myoblasts

Upregulated LncRNA-Meg3 Modulates the Proliferation and Survival of MEPM Cells Via Interacting with Smad Signaling in TCDD-induced Cleft Palate.

Involvement of METTL3-mediated m6A methylation in the early development of porcine cloned embryos

Prmt1 Regulates Craniofacial Bone Formation Upstream of Msx1

BMAL1 Deficiency Contributes to Mandibular Dysplasia by Upregulating MMP3